These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 20199673)

  • 21. Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies.
    Luong ML; Filion C; Labbé AC; Roy J; Pépin J; Cadrin-Tourigny J; Carignan S; Sheppard DC; Laverdière M
    Diagn Microbiol Infect Dis; 2010 Oct; 68(2):132-9. PubMed ID: 20846585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Analysis of the Clarus Aspergillus Galactomannan Enzyme Immunoassay Prototype for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid.
    Sedik S; Boyer J; Egger M; Dichtl K; Prattes J; Prüller F; Hoenigl M
    Mycopathologia; 2024 Jul; 189(4):67. PubMed ID: 39023825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Point-of-care diagnosis of invasive aspergillosis in non-neutropenic patients: Aspergillus Galactomannan Lateral Flow Assay versus Aspergillus-specific Lateral Flow Device test in bronchoalveolar lavage.
    Jenks JD; Mehta SR; Taplitz R; Aslam S; Reed SL; Hoenigl M
    Mycoses; 2019 Mar; 62(3):230-236. PubMed ID: 30565352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
    Park SY; Lee SO; Choi SH; Sung H; Kim MN; Choi CM; Hong SB; Oh YM; Shim TS; Koh Y; Kim YS; Woo JH; Kim SH
    J Infect; 2010 Dec; 61(6):492-8. PubMed ID: 20833201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic yield of a bronchoalveolar lavage fluid galactomannan assay in patients with negative serum galactomannan results suspected to have invasive pulmonary aspergillosis.
    Lim SY; Lee YW; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH; Kim SH
    Mycoses; 2021 Sep; 64(9):1124-1131. PubMed ID: 33740824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies.
    Bergeron A; Belle A; Sulahian A; Lacroix C; Chevret S; Raffoux E; Arnulf B; Socié G; Ribaud P; Tazi A
    Chest; 2010 Feb; 137(2):410-5. PubMed ID: 19801584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis.
    Hadrich I; Makni F; Cheikhrouhou F; Neji S; Amouri I; Sellami H; Trabelsi H; Bellaaj H; Elloumi M; Ayadi A
    Pathol Biol (Paris); 2012 Dec; 60(6):357-61. PubMed ID: 22154334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis in non-hematological patients.
    Fortún J; Martín-Dávila P; Gomez Garcia de la Pedrosa E; Silva JT; Garcia-Rodríguez J; Benito D; Venanzi E; Castaño F; Fernández-Ruiz M; Lazaro F; García-Luján R; Quiles I; Cabanillas JJ; Moreno S; Aguado JM
    J Infect; 2016 Jun; 72(6):738-744. PubMed ID: 27025205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis.
    Zhou W; Li H; Zhang Y; Huang M; He Q; Li P; Zhang F; Shi Y; Su X
    J Clin Microbiol; 2017 Jul; 55(7):2153-2161. PubMed ID: 28446576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study.
    He H; Ding L; Sun B; Li F; Zhan Q
    Crit Care; 2012 Jul; 16(4):R138. PubMed ID: 22835335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed?
    Svensson T; Lundström KL; Höglund M; Cherif H
    Ups J Med Sci; 2017 Mar; 122(1):56-60. PubMed ID: 27739337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative Real-Time PCR and Platelia Galactomannan Assay for the Diagnosis of Invasive Pulmonary Aspergillosis: Bronchoalveolar Lavage Fluid Performs Better Than Serum in Non-neutropaenic Patients.
    Zhang S; Wang S; Wan Z; Que C; Li R; Yu J
    Mycopathologia; 2016 Oct; 181(9-10):625-9. PubMed ID: 27270570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Galactomannan Tests of Bronchoalveolar Lavage Fluid for Diagnosing Invasive Pulmonary Aspergillosis].
    Deng J; Wu SY; Liu Y; Ma Y; Xie Y; Chen ZX; Dai ZQ; Deng JL; Kang M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):124-128. PubMed ID: 29737102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan.
    de Mol M; de Jongste JC; van Westreenen M; Merkus PJ; de Vries AH; Hop WC; Warris A; Janssens HM
    Pediatr Pulmonol; 2013 Aug; 48(8):789-96. PubMed ID: 22949309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients.
    Clancy CJ; Jaber RA; Leather HL; Wingard JR; Staley B; Wheat LJ; Cline CL; Rand KH; Schain D; Baz M; Nguyen MH
    J Clin Microbiol; 2007 Jun; 45(6):1759-65. PubMed ID: 17428933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis with Nonneutropenic Patients.
    Zhuang Q; Ma H; Zhang Y; Chen L; Wang L; Zheng L; Deng Z; Chen Z
    Can Respir J; 2017; 2017():3685261. PubMed ID: 29259396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspergillus galactomannan detection in exhaled breath condensate compared to bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in immunocompromised patients.
    Bhimji A; Bhaskaran A; Singer LG; Kumar D; Humar A; Pavan R; Lipton J; Kuruvilla J; Schuh A; Yee K; Minden MD; Schimmer A; Rotstein C; Keshavjee S; Mazzulli T; Husain S
    Clin Microbiol Infect; 2018 Jun; 24(6):640-645. PubMed ID: 28970160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan.
    Mikulska M; Furfaro E; De Carolis E; Drago E; Pulzato I; Borghesi ML; Zappulo E; Raiola AM; Grazia CD; Del Bono V; Cittadini G; Angelucci E; Sanguinetti M; Viscoli C
    Med Mycol; 2019 Nov; 57(8):987-996. PubMed ID: 30753590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Independent contribution of bronchoalveolar lavage and serum galactomannan in the diagnosis of invasive pulmonary aspergillosis.
    Fisher CE; Stevens AM; Leisenring W; Pergam SA; Boeckh M; Hohl TM
    Transpl Infect Dis; 2014 Jun; 16(3):505-10. PubMed ID: 24725139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic role of polymerase chain reaction in bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in immunocompromised patients - A retrospective cohort study.
    Hardak E; Fuchs E; Leskes H; Geffen Y; Zuckerman T; Oren I
    Int J Infect Dis; 2019 Jun; 83():20-25. PubMed ID: 30926540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.